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PURPOSE. We investigate the genotype and phenotype spectrum of FRMD7-associated infantile
nystagmus syndrome in Korean probands.
METHODS. A total of 37 patients with infantile nystagmus syndrome were recruited
prospectively for genetic analysis. We performed polymerase chain reaction (PCR)-based
direct sequencing and haplotype analysis for FRMD7. Detailed ophthalmic examinations and
eye movement recordings were compared between FRMD7 and non-FRMD7 groups.
RESULTS. In 13 (35%) of 37 patients, five different mutations of FRMD7 were detected: start
codon mutation c.1A>G, splice site mutation c.162þ6T>C, and three missense mutations
(c.575A>C, c.722A>G, and c.875T>C). The latter mutation was identified in seven unrelated
patients, and always was accompanied with two single nucleotide polymorphisms of exon 12
(rs6637934, rs5977623). Compared to non-FRMD7 groups, a cup-to-disc ratio was
significantly decreased in FRMD7 groups (P < 0.001), and a disc–macula distance to disc
diameter ratio markedly increased in the FRMD7 group (P ¼ 0.015). Most patients in the
FRMD7 group had at least two types of the nystagmus waveforms, and the most common type
was unidirectional jerk nystagmus (75%), such as pure jerk and jerk with extended foveation,
followed by pendular (25%), bidirectional jerk (19%), and dual jerk (6%) nystagmus. No
significant differences were observed between FRMD7 and non-FRMD7 groups in terms of the
nystagmus waveform, presence of periodic alternating nystagmus, and mean foveation time.
CONCLUSIONS. We identified five FRMD7 mutations in 35% of our infantile nystagmus syndrome
cohort, expanding its mutational spectrum. The missense mutation c.875T>C may be a
common mutation arisen from the founder effect in Korea. Optic nerve dysplasia associated
with FRMD7 mutations suggests that the abnormal development of afferent visual systems
may affect neural circuitry within the oculomotor system.
Keywords: infantile nystagmus syndrome, FRMD7, founder effect, optic nerve head dysplasia
Infantile nystagmus syndrome (INS) is characterized byinvoluntary oscillation of the eyes, which is present at birth
or manifesting within the first few months of life.1 It can be
associated with visual system disorders, such as albinism,
achromatopsia, and Leber congenital amaurosis, suggesting that
the nystagmus may be sensory in origin. On the other hand,
idiopathic IN (IIN) arises independently of any ocular or
neurologic abnormalities. This has led to speculation that IIN
may be caused by abnormal development of the ocular motor
system itself rather than the afferent visual pathway.2,3
INS is a genetically heterogeneous disorder. To date, more
than 100 genes have been associated with INS and there is
significant overlap in phenotypic characteristics.3–5 IIN may be
inherited as an autosomal dominant, autosomal recessive, or X-
linked trait.6 The most common form of inheritance is X-linked,
which can be dominant or recessive. Three X-linked loci have
been reported at Xp11.4-p.11.3, Xp22, and Xq26-q27. In 2006,
Tarpey et al.7 first identified pathogenic mutations in FRMD7
located at Xq26. Approximately 50% of families with IIN have
been linked to the FRMD7 locus. Many studies revealed that
FRMD7 protein is expressed mainly in the developing ocular
motor structures, such as the cerebellum and vestibular
nucleus, and has an important role in control of eye movement
and gaze stability.7–9 However, recent studies using optical
coherence tomography (OCT) demonstrated that individuals
with FRMD7 mutations had abnormal retinal developments,
including foveal hypoplasia and optic nerve head abnormali-
ties.10 These raise a possibility that arrested retinal develop-
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ments may be the underlying etiology in the development of
nystagmus in IIN.
We performed molecular genetic analysis on FRMD7 in a
Korean cohort with INS to identify the causative mutations. We
also investigated the ophthalmic and oculomotor characteris-
tics of patients with FRMD7 mutations to elucidate the
phenotype of FRMD7-associated INS.
METHODS
Patients
We prospectively recruited 37 unrelated Korean patients (19
men, 18 women, age range 9–67 years, mean 6 SD ¼ 33.5 6
15 years) with INS from the Neuro-ophthalmology Clinic of
two university hospitals in Korea. INS was defined as conjugate
oscillations of the eyes with onset within the first 6 months of
life.1 Other congenital forms of nystagmus, such as fusional
maldevelopment nystagmus syndrome and spasmus nutans
syndrome, were excluded. Of the patients, 13 had a family
history of INS, and the remaining 24 were sporadic cases.
All experiments followed the tenets of the Declaration of
Helsinki, and informed consent was obtained after the nature
and possible consequences of this study had been explained to
the participants. This study was approved by the institutional
review boards of two participating hospitals (Pusan National
University Hospital [PNUH] and Pusan National University
Yangsan Hospital [PNUYH]). Because our study included all
consecutive patients during the research period, two previ-
ously reported families were included in this report.11
Clinical Assessments
A total of 41 patients, including four affected members within
the family, received detailed ophthalmic examinations and eye
movement recording. The ophthalmic examinations included
best-corrected visual acuity (BCVA), color vision, and anterior
segment observation with slit-lamp biomicroscopy. Visual acuity
was measured using the Snellen chart and converted to logMAR
for subsequent analysis. We evaluated color vision through
Ishihara testing. Optic nerve dysplasia was assessed by
morphologic analysis of the optic nerve head, including
peripapillary pigment and double ring sign from fundus
photographs. We also measured the cup-to-disc ratio (C/D ratio)
and the disc–macula distance to disc diameter ratio (DM:DD
ratio) as previously described.12,13 When the DM:DD ratio was
greater than 3.0, small optic disc could be suspected.12,13
Eye movements were recorded binocularly using infrared
video-oculography (SLMED, Seoul, Korea). Spontaneous nystag-
mus was analyzed with and without fixation while the subjects
attempted to look straight ahead. Types of waveforms were
classified based on the 12 waveforms described by Dell’Osso
and Daroff.14 In this study, we included patients with oculo-
graphically diagnosed INS that exhibited distinctive waveforms,
including increasing exponential slow phases or pendular type.
Foveation time was measured from at least 40 beats of
nystagmus as previously described, which was defined as a
relatively constant eye position that occurred during an
oscillatory cycle and lasted for at least 40 ms.15,16 Periodic
alternating nystagmus (PAN) was identified from prolonged
periods of recording over at least 10 minutes. Cycle duration
and presence of periodicity were evaluated based on the
previous report.17 We also evaluated the effects of convergence.
Mutation Analysis
We screened mutations in FRMD7 by direct sequence analysis
using genomic DNA from peripheral blood of the patients. All
coding exons and intron–exon junctions from FRMD7 were
amplified through polymerase chain reaction (PCR) with the
primers listed in a previous study.11 PCR-amplified products
were separated and purified using 2% agarose gel and a DNA
extraction kit (SolGent, Daejeon, Korea), cycle-sequenced with
PCR primers using the BigDye Terminator Sequencing Kit
(Applied Biosystems, Foster, CA, USA), and electrophoresed
using an ABI PRISM 3730XL DNA analyzer (Applied Biosys-
tems). We manually examined sequences for variants using
Chromas software. The reference cDNA sequence was
obtained from the Genbank database (NM_194277.1), when
c.1 corresponds to the first nucleotide of the translation
initiation codon. The variant was tested for novelty through
searches of literature and public variant database, including the
Human Gene Mutation Database (HGMD), Korean Personal
Genome Project (KPGP) information, dbSNP147, the Exome
Aggregation Consortium (ExAC), and the 1000 Genomes
Project. Pathogenicity of nonsynonymous variants was ana-
lyzed using the following predictive software: SIFT (J. Craig
Venter Institute; http://sift.jcvi.org/), PROVEAN (J. Craig
Venter Institute; http://provean.jcvi.org/), and Mutation Taster
(Charite´ Universita¨tsmedizin Berlin; http://mutationtaster.org/
). We evaluated conservation at the base position using
PhastCons (available in the public domain, http://compgen.
cshl.edu/phast/). The variants were evaluated further in 150
normal controls using PCR and restriction fragment length
polymorphism (PCR-RFLP) analysis.
Haplotype Analysis
To determine whether FRMD7 mutations represent a founder
effect, we performed haplotype analysis using the Axiom SNP
array. Briefly, purified genomic DNA of the patients was
amplified and fragmented. Then, a single-strand DNA fragment
by denaturation was transferred to the HT hybridization Tray
and loaded on the Axiom GeneTitan (Affymetrix, Santa Clara,
CA, USA). The Hybridization Tray and the Custom 96 array
plate moved to the Axiom GeneTitan were combined and
reacted for 23 hours 30 minutes at a uniform temperature and
then stained. Allele calling was performed using generated
‘CEL files’ with Axiom Analysis Suite (1.1.0.616). Axiom best
practice workflow was followed to obtain high-quality
genotyping results (available in the public domain at https://
biobank.ctsu.ox.ac.uk/crystal/docs/axiom_geno_analguide.
pdf). Samples with DQC < 0.82 and QC call rate < 97% were
not considered for further analysis. PED/MAP files were
generated after QC. We used 26 intragenic single nucleotide
polymorphisms (SNPs) located in coding region or introns of
FRMD7 (See Supplementary Table S1), and conducted linkage
disequilibrium (LD) block analysis using markers with minor
allele frequency (MAF) > 0.01.
Molecular Structural Modeling of Missense
Mutations
Structural modeling of wild type and mutants of human FRMD7
FERM domain comprising residues 1 to 282 was performed
using I-TASSER. The crystal structure of FERM domain of
human protein DAL-1 (PDB accession code: 2HE7) having 40%
sequence identity was used as a template. The resultant PDB
files were visualized by Pymol (available in the public domain
at www.pymol.org).
Statistical Analysis
A Mann-Whitney U test was used to compare continuous
variables (visual acuity, C/D ratio, DM:DD ratio, mean foveation
time of nystagmus) between FRMD7 and non-FRMD7 groups.
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Categorical variables were compared using the Pearson’s v2
test or Fisher’s exact test between two groups.
RESULTS
Molecular Genetic Results
The patient’s molecular findings are summarized in Table 1 and
Figure 1A. Five different mutations were detected in 13 (35%)
of 37 unrelated patients. Six patients had a family history of INS
(Fig. 2). Four mutations were novel: start codon mutation
c.1A>G (p.M1V), splice site mutation c.162þ6T>C, and two
missense mutations c.575A>C (p.H192P) and c.722A>G
(p.K241R). The remaining one was reported previously:
missense mutation c.875T>C (p.L292P).18 All mutations were
not found in 150 healthy controls.
We detected c.1A>G of exon 1 in two unrelated families (F1
and 2). The mutation leads to loss of the primary start codon
ATG for methionine, which is replaced by a triplet GTG for
valine. The alternative in-frame start codon is not present
around a mutation. This mutation also was detected in another
affected member within each family. In F3, a splice-site
mutation was found at the 6th nucleotide of the splice donor
site on intron 2 (c.162þ6T>C). The mutation also was detected
in proband’s mother and absent in public databases. Human
Splicing Finder (HSF) predicted that this mutation will break
the splice site and make new splice sites resulting in four bases
longer on exon 2. A missense mutation c.575A>C of exon 7
was identified in two unrelated families (F5 and 6). The
mutation would result in amino acid substitution of histidine
by proline at codon 192. Another missense mutation was
c.722A>G of exon 8 in a sporadic case (S20), which changed a
highly conserved amino acid lysine by glycine at codon 241.
Both missense mutations were absent in public databases and
predicted to be pathogenic by all three prediction tools. The
last mutation was the known missense mutation c.875T>C,
which was found in a Belgian family with IIN.18 In our cohort,
this mutation was detected in seven patients, including one
family (F4) and six sporadic cases (S2, S3, S4, S9, S10, and S15).
It had a MAF of 0.0003 in the 1000 Genomes Project and
0.00003 in the ExAC Browser, but was absent in in-house
controls. It was predicted to be pathogenic by all prediction
tools, and the mutated residue of leucine was highly
conserved.
Haplotype analysis was performed in seven unrelated
patients with the c.875T>C mutation (See Supplementary
Table S1). In SNPs analysis, we could not establish any LD
among the SNPs within FRMD7. Furthermore, the 5000 kb
region around FRMD7 showed no LD. However, direct
sequence analysis of FRMD7 revealed that the c.875T>C
mutation always was observed with two SNPs of exon 12,
including c.1403G>A (rs6637934, MAF ¼ 0.066) and
c.1533T>C (rs5977623, MAF ¼ 0.259; Fig. 1A). These SNPs
were not observed in patients with another FRMD7 mutations
except for c.162þ6T>C (Table 2).
Protein Structural Modeling
Figure 1B shows the structural modeling of novel missense
mutations (p.H192P and p.K241R). The H192 residue is
located in the middle of the b-sheets within F3-FERM domain.
Therefore, the p.H192P mutation is likely to destabilize the
overall structure of FRMD7 by disrupting the core b-strand
conformation. On the other hand, the effect caused by the
p.K241R mutation is not clearly apparent because it is located
at the end of the predicted b-strand. Moreover, the side chain
of lysine (K) is structurally similar to that of arginine (R),T
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suggesting that the mutation from lysine to arginine in this
residue might not significantly affect overall structure.
Clinical Characteristics
Detailed ophthalmic and oculomotor findings of patients with
FRMD7 mutations are summarized in Supplementary Tables S2
and S3. Comparisons of clinical characteristics between
patients with and without FRMD7 mutations are described in
Table 3. In the FRMD7 group, the mean C/D ratio was below
normal range (0.33 6 0.15, normal 0.4~0.6), and significantly
decreased compared to that in the non-FRMD7 group (0.51 6
0.20, P < 0.001; Fig. 3), whereas the mean DM:DD ratio
considerably increased in the FRMD7 group (3.04 6 0.53)
compared to the non-FRMD7 group (2.80 6 0.37, P¼ 0.015).
Four patients in the FRMD7 group had morphologic changes of
the optic nerve head, including segmental hypoplasia (II1 of F1
and III6 of F4) and peripapillary pigment (S15 and S20). None
of the FRMD7 group patients had macular hypoplasia or
anomalies of anterior segments. The FRMD7 group had a
better visual acuity than the non-FRMD7 group, but there were
no significant differences in color vision abnormalities and
presence of strabismus between the groups.
The waveforms of nystagmus were classified into the 12
categories of pendular, jerk (uni- and bidirectional), and dual
jerk waveforms. Most patients in the FRMD7 group had at least
two types of waveforms. The most common type was
unidirectional jerk nystagmus (75%), such as pure jerk and
jerk with extended foveation, followed by pendular (25%),
bidirectional jerk (19%), and dual jerk (6%) nystagmus. Two
patients in the FRMD7 group had a PAN with a periodic (S2) or
an aperiodic (S4) cycle. Foveation time ranged from 59 to 158
ms (mean 6 SD ¼ 100 6 30 ms) in the FRMD7 group. No
significant differences were observed between the FRMD7 and
non-FRMD7 groups in terms of waveform of nystagmus (Fig.
4), presence of PAN, mean foveation time, nystagmus changes
in darkness, and convergence effect for the nystagmus.
DISCUSSION
We identified five FRMD7 mutations in 35% (13/37) of our total
INS cohort. Four of them were novel mutations. Interestingly,
some unrelated patients had the same mutation, and the
known mutation of p.L292P was found in 54% (7/13) of the
FRMD7 group. In addition, the mutation detection rate of
sporadic cases (7/24, 29%) was higher than that in other
studies. Our study supported that FRMD7 mutations are the
underlying pathogenesis of the molecular mechanism for INS.
The FRMD7 consists of 12 exons and encodes a 714-residue
polypeptide.6,19 It contains a conserved N-terminal FERM
domain and FERM-adjacent (FA) domain, whereas the C-
terminal region has no significant homology to other pro-
TABLE 2. Patterns of Two SNPs in Patients With FRMD7 Mutations
Pathogenic
Mutations
Patient
ID
rs6637934
(c.1403G>A)
rs5977623
(c.1533T>C)
c.1A>G, p.M1V F1 GG TT
F2 GG TT
c.162þ6T>C F3 A (hemizygous) C (hemizygous)
c.575A>C,
p.H192P
F5 G (hemizygous) T (hemizygous)
F6 G (hemizygous) T (hemizygous)
c.722A>G,
p.K241R
S20 G (hemizygous) T (hemizygous)
c.875T>C,
p.L292P
F4 G/A (heterozygous) T/C (heterozygous)
S2 A (hemizygous) C (hemizygous)
S3 A (hemizygous) C (hemizygous)
S4 A (hemizygous) C (hemizygous)
S9 G/A (heterozygous) T/C (heterozygous)
S10 G/A (heterozygous) T/C (heterozygous)
S15 A (hemizygous) C (hemizygous)
FIGURE 1. Localization of FRMD7 mutations and protein structural modeling of two novel mutations. (A) The FRMD7 contains an N-terminal FERM
domain (F1, F2, and F3 lobes) and FERM-adjacent (FA) domain. The positions of the mutations are indicated at the bottom of the Figure (arrow). All
patients carrying the c.875T>C mutation share two SNPs (c.1403G>A, rs6637934; c.1533T>C, rs5977623) of exon 12 within FRMD7. (B) The
ribbon diagram shows a superposition of structural model of the FERM domains of FRMD7 of wild type (yellow), K241R (pink), and H192P (cyan)
mutants.
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teins.19 The FRMD7 protein is expressed in the developing
brain, which control eye movements and gaze stability, and has
been shown to involve regulation of neuronal cytoskeletal
dynamics through CASK-induced or Rho GTPase signal-
ing.4,20–23 Thus, FRMD7 mutations can cause abnormal eye
movements and gaze instability. To date, over 70 different
mutations within FRMD7 have been reported.5,7,9–11,18,19,24–27
Many mutations cluster around the F3 lobes of the FERM and
FA domains. This suggests that these domains have important
roles in the function of FRMD7. Three (p.H192P, p.K241R, and
p.L292P) of our mutations are located in the F3 lobe and FA
domain. The molecular structural modeling reveals that
p.H192P mutation is likely to destabilize the overall structure
of FRMD7 protein by disrupting the core b-strand conforma-
tion, but the effect of p.K241R mutation is not clearly
apparent. Previously, p.L292P mutation, which is located in
FIGURE 3. C/D and DM:DD ratio of the patients. Mean C/D (A) and DM:DD (B) ratios are significantly different between the FRMD7 and non-
FRMD7 groups.
FIGURE 2. Pedigree of six patients with FRMD7 mutations who had a family history of INS.
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the FA domain was predicted to lead to change in a-helix
conformation of the FA domain due to lack of a hydrogen on
the amino group of proline and can also affect the recognition
specificity of the hydrophobic ligands.18 However, these
structural predictions must be verified using X-ray crystallog-
raphy.
Among our mutations, the p.L292P mutation accounted for
more than 50% of total patients with FRMD7 mutations. All
patients carrying the p.L292P mutation came from the same
restricted region (Gyeongsangnam-do) of Korea and shared
common SNPs (rs6637934, rs5977623) of exon 12 within
FRMD7. c.1403G>A (rs6637934) of two SNPs is a relatively
rare variant with a MAF of 0.066, and also has been detected in
another Korean INS family with the p.L292P mutation.28 These
findings suggest that the p.L292P mutation might have arisen
from the founder effect. The size of the shared haplotype may
be small, because SNP analysis did not show LD around
FRMD7. Historically, Gyeonsangnam-do, which is located in
the southeast region of Korea, had been a part of the Silla of
Three Kingdoms period in ancient times. In this region, a
population mixing with neighboring populations was not easy
due to geographic position, and there is a distinctive dialect
and lifestyle. The fact that other mutations (p.M1V and
p.H192P) also were detected in two unrelated families
supports this explanation.
FRMD7 mutation is known to be linked to idiopathic INS
without any abnormalities in visual systems. Our patients with
FRMD7 mutations also showed relatively good vision without
anomalies of anterior segments and macular hypoplasia. This
leads to the assumption that FRMD7 mutations cause a primary
defect in regions of the brain responsible for ocular motor
control. However, the FRMD7 group in our study had a small
C/D ratio and high DM:DD ratio, suggesting morphologic
changes within the optic nerve head.12,13 Previous studies with
OCT revealed retinal and optic nerve changes, including a
shallow foveal pit, increased central macular thickness,
decreased peripapillary retinal nerve fiber layer thickness,
and shallow optic nerve cup in IIN patients with FRMD7
mutations.10,29 They demonstrated FRMD7 mRNA expressions
in the developing human retina and optic disc. We also
reported anomalous appearances of the optic nerve head using
OCT in patients with FRMD7 mutations.11 Recently, FRMD7
expression has been localized in starburst cells of the retina to
establish spatially asymmetric inhibitory inputs to direction-
selective ganglion cells (DS cells) along the horizontal axis.30
The dysfunction of FRMD7 might contribute to the lack of the
horizontal optokinetic reflex by loss of horizontal direction
selectivity. These findings reflect that the abnormal develop-
ment of afferent visual systems may be associated with FRMD7
mutations and could affect neural circuitry within the
oculomotor system.
Few studies have systematically investigated the nystagmus
pattern of patients with FRMD7 mutations.31–33 In our FRMD7
group, unidirectional jerk nystagmus was the most common
waveform, while pendular nystagmus was less common (25%)
than in previous reports (approximately 45%).31,32 There was
intra- and interfamily variability in the nystagmus waveforms,
and the phenotypes were not affected by the type of mutation.
Although PAN was observed in two patients with the p.L292P
mutation, another patient with the same mutation had no PAN.
Previously, idiopathic infantile PAN associated with other
FRMD7 mutations has been reported.33 These findings are in
accordance with those of previous reports supporting the
phenotypic variability of FRMD7 mutations.31–33 Furthermore,
we could find no difference in nystagmus characteristics
between patients with and without FRMD7 mutations. This
implied the complex mechanisms to generate various wave-
forms associated with INS, which include abnormal neural
circuitry of the slow eye movement and gaze-holding
systems.34–36 This could be explained by the effect of other
modifier genes or environmental factors. Alternatively, FRMD7
mutation alone is insufficient to generate nystagmus, but
cerebellar plasticity may amplify and shape nystagmus
waveforms similar to the hypothesis of oculopalatal tremor.4,37
The learning process in the cerebellum can be variable and
diverse among individuals. Indeed, a previous study using a
functional MRI identified the declive of the cerebellum as a
possible site of the ocular motor network involved in INS.38
This study has potential limitations. We did not check the
binocular visual acuity. It would be more likely to represent the
BCVA than monocular visual acuity in patients with nystagmus.
Furthermore, we did not perform quantitative approaches of
foveal hypoplasia and optic nerve changes using OCT imaging.
The quantitative OCT measurements can achieve analysis of
afferent visual systems in much greater detail than fundus
photography.
In conclusion, we identified five FRMD7 mutations in our
INS cohort. In particular, the missense mutation c.875T>C
may be a common mutation arisen from the founder effect in
Korea. Our results expand the mutation spectrum of FRMD7
and provide molecular evidence for the underlying pathogen-
esis of INS. Optic nerve dysplasia associated with FRMD7
mutations suggested that the abnormal development of
afferent visual systems may affect neural circuitry within the
oculomotor system.
TABLE 3. Comparisons of Clinical Characteristics Between FRMD7
and Non-FRMD7 Groups
FRMD7
group,
n ¼ 16
Non-FRMD7
group,
n ¼ 25 P Value
Sex, male, n (%) 10 (63) 13 (52) 0.453
Visual acuity, logMAR
Right eye þ0.25 þ0.75 0.051
Left eye þ0.21 þ0.67 0.006
Color vision abnormality,
n (%)
1 (7) 2 (10) 0.773
Strabismus, n (%) 2 (15) 4 (18) 1.000
Anomaly of anterior segment,
n (%)
0 (0) 8 (33) 0.015
Macular hypoplasia, n (%) 0 (0) 6 (29) 0.041
C/D ratio, mean 6 SD 0.33 6 0.15 0.51 6 0.20 <0.001
DM:DD ratio, mean 6 SD 3.04 6 0.53 2.80 6 0.37 0.015
Waveform of nystagmus, n (%)
Pendular 4 (25) 7 (28) 0.564
Unidirectional jerk 12 (75) 23 (92) 0.147
Bidirectional jerk 3 (19) 4 (16) 0.569
Dual jerk 1 (6) 1 (4) 0.634
PAN, n (%) 2 (16) 7 (25) 0.441
Foveation time of nystagmus,
mean 6 SD (ms)
100 6 30 108 6 39 0.429
Nystagmus change in
darkness, n (%)
Augmentation 0 (0) 4 (20) 0.124
Suppression 6 (38) 8 (40) 0.832
No change 6 (38) 7 (35) 0.943
Directional change 4 (25) 1 (5) 0.141
Nystagmus change during
convergence, n (%)
Augmentation 2 (13) 0 (0) 0.483
Suppression 9 (60) 8 (62) 0.713
No change 3 (20) 4 (31) 0.427
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